Breaking Fuel Shortage Grips Iraq’s Kurdish Region Amidst Security Concerns UK Government Announces Funding Cut to Historic Lovell Telescope Indiana Football Dominates Big Ten Preseason Honors Nine Journalists Convicted in Azerbaijan, Sentenced to Prison Uganda Declares End to Ebola Outbreak

Tuesday July 28, 2026

Reporter

Dyne Therapeutics, Inc.

4Articles Published

5Communities Covered

Published Articles

Press Release

Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

6 hours ago

Press Release

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 24

Press Release

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Jul 23

Press Release

Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock

Jul 21